Cookies

Like most websites The Translational Scientist uses cookies. In order to deliver a personalized, responsive service and to improve the site, we remember and store information about how you use it. Learn more.

Outside the Lab

Outside the Lab

Innovation Versus Exnovation

| Roisin McGuigan |

Sometimes, medical innovation may need to go backwards to go forwards

Outside the Lab

Trust Me, I’m a Doctor

| Roisin McGuigan |

Lack of faith in the healthcare system could be causing non-adherence in cancer patients

Outside the Lab

The Cost of Treating Cancer

| Roisin McGuigan |

When you crunch the numbers on drug development, are the costs of cancer drugs justified?

Outside the Lab

TRI a New Kind of Spectrometer

| Michael Schubert |

An inexpensive, smartphone-based device could offer a wide range of point-of-care tests.

Outside the Lab

“May I Enjoy Life and Art”

| Ruth Steer |

Research shows that art training can improve ophthalmologists’ observational skills.

Outside the Lab

Tackling Old Age Before Birth

| Beth Curtis |

Understanding the factors that influence epigenetic changes throughout life can help treat disease.

Outside the Lab

Too Pregnant to Participate

| Roisin McGuigan |

Are current ethical guidelines for clinical studies letting pregnant women down?

Outside the Lab

Undoing the Damage

| Roisin McGuigan |

Two drugs have shown potential to reverse brain damage in mice following alcohol exposure in the womb

Outside the Lab

"Sexy" Needs Substance

| Rajesh Rao |

We need to explain the context when using “grab bag” phrases in science and medicine

Outside the Lab

Pulling Back the Pre-Clinical Curtain

| William Aryitey |

Are mouse models the best option we have?

Register here

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:

  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts

Register